title: GAD antibodies seldom disappear in slowly progressive IDDM.
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
authors.forename: K
authors.initials: K
authors.lastname: Nakanishi
authors.forename: M
authors.initials: M
authors.lastname: Okubo
authors.forename: T
authors.initials: T
authors.lastname: Murase
authors.forename: K
authors.initials: K
authors.lastname: Kosaka
mesh_terms: D001323:Autoantibodies / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000276:immunology* / Q000628:therapy; D003927:Diet, Diabetic; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007515:Islets of Langerhans / Q000276:immunology / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D011336:Probability; D011446:Prospective Studies; D013997:Time Factors
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D007004:Hypoglycemic Agents; D007328:Insulin; C024211:islet cell antibody; D005968:Glutamate Decarboxylase